Previous
More than 11,000 solar panels are being deployed onto GlaxoSmithKline Consumer Healthcare's regional distribution center in York, Pa. Last year, the pharmaceutical giant spent $6.2 billion in R&D worldwide. (GlaxoSmithKline/PRNewsFoto/File )
9. GlaxoSmithKline
The London-based pharmaceutical company invested about $6.2 billion in R&D, a 12.7 percent increase from 2008. That’s the largest jump of any Top 10 company, according to Booz & Co. GlaxoSmithKline was the fourth-largest pharmaceutical company based on revenue in 2009, reporting almost $46 billion, and formed in 2000 after a merger between GlaxoWellcome and SmithKline Beecham, both of London. With 13 R&D locations worldwide, the company has its sights set on new products. Recent developments include an H1N1 vaccine and a patent pool to investigate neglected tropical diseases.
These comments are not screened before publication. Constructive debate about the above story is welcome, but personal attacks are not. Please do not post comments that are commercial in nature or that violate any copyright[s]. Comments that we regard as obscene, defamatory, or intended to incite violence will be removed. If you find a comment offensive, you may flag it.